![香港财富管理将取代瑞士称王!谁卷起香港钱潮?](https://i-invdn-com.investing.com/news/LYNXMPEB000OS_S.jpg)
注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
PaxMedica Inc是一家临床阶段的生物制药公司。该公司专注于开发抗嘌呤能药物疗法(APT),用于治疗具有难治性神经症状的疾病,包括神经发育障碍,包括自闭症谱系障碍(ASD),以及肌痛性脑脊髓炎/慢性疲劳综合征(ME/CFS)。其候选产品包括PAX-101和PAX-102。其主要项目PAX-01是苏拉明的静脉制剂,用于治疗ASD,并提高对使用该药物治疗其他疾病的临床理解,例如ME/CFS和长新冠肺炎综合征(LCS)。该公司还专注于开发PAX-101用于治疗东非人非洲锥虫病(HAT),该病由寄生虫布氏罗得西亚锥虫引起。它还专注于开发PAX-102,这是用于神经适应症的苏拉明鼻内制剂。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Constance Smith-Hicks | - | - | Member of Scientific Advisory Board |
Zachary Rome | 39 | 2019 | Director |
Reymundo Lozano | - | - | Member of Advisory Board |
Alice Mao | - | - | Member of Scientific Advisory Board |
Veronica Martinez Cerdeno | - | - | Member of Advisory Board |
Andrew J. Cutler | - | 2023 | Member of Scientific Advisory Board |
John F. Coelho | 54 | 2022 | Independent Director |
Charles J. Casamento | 78 | 2022 | Lead Independent Director |
Robert K. Naviaux | - | - | Member of Scientific Advisory Board |
Vladimir Maletic | - | 2023 | Member of Scientific Advisory Board |
Rakesh Jain | - | 2023 | Member of Scientific Advisory Board |
Robert Findling | - | 2023 | Member of Scientific Advisory Board |
Karen J. LaRochelle | 56 | 2020 | Independent Director |
Michael Aman | - | - | Member of Scientific Advisory Board |
Stefan K. F. Schwabe | 71 | 2022 | Member of Scientific Advisory Board |
Howard J. Weisman | 64 | 2020 | CEO & Chairman |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核